{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:53:06Z","timestamp":1761519186658,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.4158\/ep161523.or","type":"journal-article","created":{"date-parts":[[2017,4,24]],"date-time":"2017-04-24T16:50:41Z","timestamp":1493052641000},"page":"466-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prediction Of Relapse From Hyperthyroidism Following Antithyroid Medication Withdrawal Using Technetium Thyroid Uptake Scanning"],"prefix":"10.1016","volume":"23","author":[{"given":"Manouchehr","family":"Nakhjavani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soraya","family":"Abdollahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Farzanefar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadtagi","family":"Abousaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Esteghamati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Naseri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamad","family":"Eftekhari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehrshad","family":"Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP161523.OR_bb0010","first-page":"69","article-title":"Recurrence and prognostic factors after treatment with antithyroid agents in Graves'-Basedow disease [in Spanish]","volume":"200","author":"Men\u00e9ndez","year":"2000","journal-title":"Rev Clin Esp"},{"key":"10.4158\/EP161523.OR_bb0015","first-page":"126","article-title":"Identifying risk factors for relapse in Graves' disease: a retrospective study","volume":"12","author":"Jivanjee","year":"2006","journal-title":"Endocr Abstracts"},{"key":"10.4158\/EP161523.OR_bb0020","first-page":"689","article-title":"Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease","volume":"120","author":"Schleusener","year":"1989","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4158\/EP161523.OR_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2265.1989.tb01244.x","article-title":"Antithyroid drugs in the treatment of hyperthyroidism of Graves' disease: long-term follow up of 434 patients. Scottish Automated Follow-Up Register Group","volume":"31","author":"Hedley","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161523.OR_bb0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.31661\/gmj.v1i1.4","article-title":"The effect of methimazole on thyroid gland uptake of technetium in hyperthyroid patients","volume":"1","author":"Gheisari","year":"2012","journal-title":"GMJ"},{"key":"10.4158\/EP161523.OR_bb0035","doi-asserted-by":"crossref","first-page":"615","DOI":"10.4158\/EP.13.6.615","article-title":"Serum thyrotropin in Graves' disease: a more reliable index of circulating thyroid-stimulating immunoglobulin level than thyroid function?","volume":"13","author":"Kabadi","year":"2007","journal-title":"Endocr Pract"},{"key":"10.4158\/EP161523.OR_bb0040","first-page":"173","article-title":"Thyroid blood flow and uptake of technetium-99m pertechnetate in Graves' disease","volume":"9","author":"Sekuli\u0107","year":"2006","journal-title":"Hell J Nucl Med"},{"key":"10.4158\/EP161523.OR_bb0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF01731833","article-title":"Prediction of remission in Graves' disease treated with long-term carbimazole therapy: evaluation of technetium-99m thyroid uptake and TSH concentrations as prognostic indicators","volume":"23","author":"Prakash","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.4158\/EP161523.OR_bb0050","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0002-9343(90)90296-P","article-title":"Serum thyroglobulin concentration as an indicator for assessing thyroid stimulation in patients with Graves' disease during antithyroid drug therapy","volume":"89","author":"Aizawa","year":"1990","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"10.4158\/EP161523.OR_bb0055","doi-asserted-by":"crossref","first-page":"S453","DOI":"10.1007\/s00259-002-0831-4","article-title":"Strategies of radioiodine therapy for Graves' disease","volume":"29","author":"Lind","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.4158\/EP161523.OR_bb0060","first-page":"520","article-title":"Thyroid-stimulating immunoglobulins. The related antigens [in French]","volume":"43","author":"Pinchera","year":"1982","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.4158\/EP161523.OR_bb0065","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1507\/endocrj.52.493","article-title":"Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease","volume":"52","author":"Izumi","year":"2005","journal-title":"Endocr J"},{"key":"10.4158\/EP161523.OR_bb0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2007-957347","article-title":"Improved prediction of relapse of Graves' thyrotoxicosis by combined determination of TSH receptor and thyroperoxidase antibodies","volume":"39","author":"Schott","year":"2007","journal-title":"Horm Metab Res"},{"key":"10.4158\/EP161523.OR_bb0075","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12020-013-9895-0","article-title":"Predictors of long-term remission in patients with Graves' disease: a single center experience","volume":"44","author":"Anagnostis","year":"2013","journal-title":"Endocrine"},{"issue":"Suppl 1","key":"10.4158\/EP161523.OR_bb0080","first-page":"53","article-title":"Antithyroid drug therapy: predictive parameters","volume":"93","author":"Feldt-Rasmussen","year":"1999","journal-title":"Z Arztl Fortbild Qualitatssich"},{"key":"10.4158\/EP161523.OR_bb0085","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrendo.2013.193","article-title":"Diagnosis and management of Graves disease: a global overview","volume":"9","author":"Bartalena","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.4158\/EP161523.OR_bb0090","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2214\/ajr.132.2.249","article-title":"Simple, rapid thyroid function testing with 99mTc-pertechnetate thyroid uptake ratio and neck\/thigh ratio","volume":"132","author":"Schneider","year":"1979","journal-title":"AJR Am J Roentgenol"},{"key":"10.4158\/EP161523.OR_bb0095","first-page":"907","article-title":"20-Min 99mTc thyroid uptake: a simplified method using the gamma camera","volume":"14","author":"Higgins","year":"1973","journal-title":"J Nucl Med"},{"key":"10.4158\/EP161523.OR_bb0100","first-page":"659","article-title":"The diagnostic and prognostic value of the 20 min 99mTc-uptake in the thyroid gland","volume":"74","author":"Kirkegaard","year":"1973","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.4158\/EP161523.OR_bb0105","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00003072-199606000-00005","article-title":"Serial occurrence of two types of postpartum thyroid disorders: Usefulness of Tc-99m pertechnetate uptake","volume":"21","author":"Misaki","year":"1996","journal-title":"Clin Nucl Med"},{"key":"10.4158\/EP161523.OR_bb0110","first-page":"785","article-title":"Simultaneous measurement of thyroidal trapping (99mTcO4-) and binding (131I-): clinical and experimental studies in man","volume":"14","author":"Hays","year":"1973","journal-title":"J Nucl Med"},{"key":"10.4158\/EP161523.OR_bb0115","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1272\/jnms.73.10","article-title":"Analysis of the factors associated with Tc-99m pertechnetate uptake in thyrotoxicosis and graves' disease","volume":"73","author":"Kidokoro-Kunii","year":"2006","journal-title":"J Nippon Med Sch"},{"issue":"Suppl 2","key":"10.4158\/EP161523.OR_bb0120","doi-asserted-by":"crossref","first-page":"S425","DOI":"10.1007\/s00259-002-0811-8","article-title":"The continuing importance of thyroid scintigraphy in the era of high resolution ultrasound","volume":"29","author":"Meller","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.4158\/EP161523.OR_bb0125","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF03164594","article-title":"Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake","volume":"4","author":"Ikekubo","year":"1990","journal-title":"Ann Nucl Med"},{"key":"10.4158\/EP161523.OR_bb0130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/BF03348175","article-title":"Thyroid stimulating immunoglobulin bioactivity during carbimazole therapy as measured by the cytochemical bioassay","volume":"10","author":"Prentice","year":"1987","journal-title":"J Endocrinol Invest"},{"key":"10.4158\/EP161523.OR_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2265.1987.tb00795.x","article-title":"Cellular and humoral immunity in patients with hyperthyroid Graves' disease before, during and after antithyroid drug treatment","volume":"26","author":"van Ouwerkerk","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161523.OR_bb0140","first-page":"293","article-title":"Thyroid stimulating immunoglobulin in Graves' disease","volume":"11","author":"Luttrell","year":"1981","journal-title":"Aust N Z J Med"},{"key":"10.4158\/EP161523.OR_bb0145","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.acra.2010.01.014","article-title":"Diffusion-weighed MR of the thyroid gland in Graves' disease: assessment of disease activity and prediction of outcome","volume":"17","author":"Abdel Razek","year":"2010","journal-title":"Acad Radiol"},{"key":"10.4158\/EP161523.OR_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1258\/rsmacta.41.1.45","article-title":"Doppler ultrasonography in predicting relapse of hyperthyroidism in Graves' disease","volume":"41","author":"Varsamidis","year":"2000","journal-title":"Acta Radiol"},{"key":"10.4158\/EP161523.OR_bb0155","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biopha.2009.04.038","article-title":"Thyroid blood flow as a useful predictor of relapse of Graves' disease after normal delivery in patients with Graves' disease","volume":"64","author":"Nagasaki","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"10.4158\/EP161523.OR_bb0160","first-page":"7","article-title":"Cost-effectiveness analysis: radioiodine or antithyroid medication in primary treatment of immune hyperthyroidism [in German]","volume":"38","author":"Dietlein","year":"1999","journal-title":"Nuklearmedizin"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20360523?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20360523?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:02:31Z","timestamp":1761516151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20360523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1530891X20360523"],"URL":"https:\/\/doi.org\/10.4158\/ep161523.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction Of Relapse From Hyperthyroidism Following Antithyroid Medication Withdrawal Using Technetium Thyroid Uptake Scanning","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP161523.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}